» Articles » PMID: 12684185

Genetic Epidemiology of Insulin Resistance and Visceral Adiposity. The IRAS Family Study Design and Methods

Overview
Journal Ann Epidemiol
Publisher Elsevier
Specialty Public Health
Date 2003 Apr 10
PMID 12684185
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Insulin resistance and visceral adiposity are associated with increased risk of type 2 diabetes. In this report, we describe the methods of the IRAS Family Study, which was designed to identify the genetic and environmental risk factors for insulin resistance and visceral adiposity.

Methods: Families from two ethnic groups (African American and Hispanic) have been recruited from three clinical sites. Blood samples for DNA as well as other standard measures were collected. A CT scan (visceral adiposity) and a frequently sampled glucose tolerance test (insulin resistance) were performed. Preliminary estimates of heritability for indirect measures related to insulin resistance and visceral adiposity were obtained using a variance components approach in the first 93 families (approximately 1000 individuals).

Results: Estimates of heritability ranged from low (0.08) for fasting insulin and HOMA, to moderate (0.28) for fasting glucose, to high (0.54) for BMI. After adjustment for age, gender and ethnicity, all heritability estimates were significantly greater than zero (p < 0.05).

Conclusions: These results are consistent with the expectation that intermediate measures of insulin resistance and visceral adiposity are heritable, and that the IRAS Family Study has statistical power to detect these intermediate phenotypes of type 2 diabetes and atherosclerosis.

Citing Articles

Plasma Circulating Metabolites Associated With Steatotic Liver Disease and Liver Enzymes: A Multiplatform Population-Based Study.

Abozaid Y, Ayada I, van Kleef L, Goulding N, Williams-Nguyen J, Kaplan R Gastro Hep Adv. 2025; 4(2):100551.

PMID: 39877862 PMC: 11772964. DOI: 10.1016/j.gastha.2024.09.006.


Mutational signature analyses in multi-child families reveal sources of age-related increases in human germline mutations.

Shojaeisaadi H, Schoenrock A, Meier M, Williams A, Norris J, Palmer N Commun Biol. 2024; 7(1):1451.

PMID: 39506086 PMC: 11541588. DOI: 10.1038/s42003-024-07140-2.


Methods for estimating insulin resistance from untargeted metabolomics data.

Hsu F, Palmer N, Chen S, Ng M, Goodarzi M, Rotter J Metabolomics. 2023; 19(8):72.

PMID: 37558891 PMC: 10412652. DOI: 10.1007/s11306-023-02035-5.


Metabolomic profiling of glucose homeostasis in African Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS-FS).

Okut H, Lu Y, Palmer N, Chen Y, Taylor K, Norris J Metabolomics. 2023; 19(4):35.

PMID: 37005925 PMC: 10068644. DOI: 10.1007/s11306-023-01984-1.


Trends in insulin resistance: insights into mechanisms and therapeutic strategy.

Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H Signal Transduct Target Ther. 2022; 7(1):216.

PMID: 35794109 PMC: 9259665. DOI: 10.1038/s41392-022-01073-0.